RSNN Special Interest Group Advanced Therapies workshop & networking event
About the RSNN SIG Advanced Therapies
The Regulatory Science Network Netherlands (RSNN) recently launched the Special Interest Group (SIG) Advanced Therapies to facilitate and enhance interaction between stakeholders involved in all stages of development, assessment, and access of these products. The aim of this SIG is to identify knowledge gaps and actions to address regulatory challenges perceived by stakeholders in a multistakeholder fashion. More information on the RSNN SIG Advanced Therapies can be found here.
About the workshop & networking event
During the RSNN SIG Advanced Therapies workshop, you will be invited to provide input on challenges in ATMP development, assessment, and access as perceived by different stakeholders. This will be done through plenary identification and prioritization of challenges proposed by the multistakeholder audience. Next, in smaller groups, each challenge will be assessed in more detail on stakeholder-specific needs, implications, and responsibilities, including how to address these challenges. A plenary discussion will bring the main findings and challenges together to allow for further input from all stakeholders. Your input will be used to set the agenda for future activities of the RSNN and its partners.
You are kindly invited to reflect prior to the workshop on current challenges that impede the development, assessment, and access of Advanced Therapies, to facilitate an informed and in-depth public assessment.